drugset / Trial / NCT00828438

Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment

NCT00828438

Phase 1 Completed 40 enrolled Eisai Inc.
NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to evaluate the PK properties of lorcaserin in subjects with end stage renal disease (ESRD) who require dialysis and will be studied under dialysis and non-dialysis conditions.

Timeline

Start
2008-10
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lorcaserin Small molecule 10 mg